TR200100370T2 - Anti-konvülzan etkinliğe sahip yeni 4-amino-1-arilpiridin-2-on'lar ve bunların hazırlanması için işlemler. - Google Patents

Anti-konvülzan etkinliğe sahip yeni 4-amino-1-arilpiridin-2-on'lar ve bunların hazırlanması için işlemler.

Info

Publication number
TR200100370T2
TR200100370T2 TR2001/00370T TR200100370T TR200100370T2 TR 200100370 T2 TR200100370 T2 TR 200100370T2 TR 2001/00370 T TR2001/00370 T TR 2001/00370T TR 200100370 T TR200100370 T TR 200100370T TR 200100370 T2 TR200100370 T2 TR 200100370T2
Authority
TR
Turkey
Prior art keywords
amino
new
arylpyridine
ones
processes
Prior art date
Application number
TR2001/00370T
Other languages
English (en)
Inventor
Lankau Hans-Joachim
Unverferth Klaus
Arnold Thomas
Bartsch Reni
Rostock Angelika
Granik Vladimir
Grizik Sofia
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of TR200100370T2 publication Critical patent/TR200100370T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Bulus, formül (1)'in yeni 4-amino-1-aril-piridin-2-on bilesikleriyle ile ilgilidir ki burada n = 0,1,2,3,4,5 olmakta ve x hidrojen, C1-C4-alkil, C1-C4-alkoksi, triflorometil, triflorometoksi veya halojen olmakta ve A amino, C1-C4 alkilamino, C1-C4 dialkilamino, morfolino, piperidino, veya pirrolidino olmaktadir. Bulus, ayni zamanda bunlarin üretilme yöntemi ve tipta, tasrihen epilepsinin farkli sekillerinin tedavisinde kullanilmasi ile ilgilidir.
TR2001/00370T 1998-08-07 1999-07-28 Anti-konvülzan etkinliğe sahip yeni 4-amino-1-arilpiridin-2-on'lar ve bunların hazırlanması için işlemler. TR200100370T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19835918A DE19835918A1 (de) 1998-08-07 1998-08-07 Neue antikonvulsiv wirkende 4-Amino-1-aryl-pyridin-2-one und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
TR200100370T2 true TR200100370T2 (tr) 2001-08-21

Family

ID=7876889

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00370T TR200100370T2 (tr) 1998-08-07 1999-07-28 Anti-konvülzan etkinliğe sahip yeni 4-amino-1-arilpiridin-2-on'lar ve bunların hazırlanması için işlemler.

Country Status (21)

Country Link
US (1) US6071911A (tr)
EP (1) EP1102748A1 (tr)
JP (1) JP2002522420A (tr)
KR (1) KR20010074802A (tr)
CN (1) CN1322197A (tr)
AR (1) AR021186A1 (tr)
AU (1) AU5507499A (tr)
BG (1) BG105196A (tr)
BR (1) BR9912849A (tr)
CA (1) CA2279692C (tr)
DE (1) DE19835918A1 (tr)
HU (1) HUP0103204A3 (tr)
IL (1) IL141200A0 (tr)
NO (1) NO20010575L (tr)
NZ (1) NZ509914A (tr)
PL (1) PL346013A1 (tr)
RU (1) RU2001106634A (tr)
SK (1) SK2002001A3 (tr)
TR (1) TR200100370T2 (tr)
WO (1) WO2000007988A1 (tr)
ZA (1) ZA200100999B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ522773A (en) 2000-06-12 2005-06-24 Eisai Co Ltd 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
GB0129260D0 (en) 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
MY148809A (en) 2004-07-06 2013-05-31 Eisai R&D Man Co Ltd Crystals of 1,2-dihydropyridine compound and their production process
WO2020124090A1 (en) 2018-12-14 2020-06-18 Eisai R&D Management Co., Ltd. Aqueous based pharmaceutical formulations of 1,2-dihydropyridine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118768A (en) * 1975-02-19 1976-10-18 Shigeo Senda Method for preparing 4-amino-2-pyridone derivatives
ATE25078T1 (de) * 1982-10-27 1987-02-15 Degussa 2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.

Also Published As

Publication number Publication date
CA2279692C (en) 2003-10-07
PL346013A1 (en) 2002-01-14
US6071911A (en) 2000-06-06
WO2000007988A1 (de) 2000-02-17
ZA200100999B (en) 2001-12-14
AU5507499A (en) 2000-02-28
DE19835918A1 (de) 2000-02-10
NO20010575D0 (no) 2001-02-02
AR021186A1 (es) 2002-07-03
SK2002001A3 (en) 2002-01-07
RU2001106634A (ru) 2004-02-27
NO20010575L (no) 2001-04-04
CA2279692A1 (en) 2000-02-07
KR20010074802A (ko) 2001-08-09
IL141200A0 (en) 2002-02-10
BR9912849A (pt) 2001-05-08
HUP0103204A3 (en) 2002-06-28
BG105196A (en) 2001-12-29
HUP0103204A2 (hu) 2002-04-29
JP2002522420A (ja) 2002-07-23
NZ509914A (en) 2002-11-26
CN1322197A (zh) 2001-11-14
EP1102748A1 (de) 2001-05-30

Similar Documents

Publication Publication Date Title
DE69213099T2 (de) Eisen-Chrom-Aluminiumlegierung, Verwendung dieser Legierung für Katalysatorträger und Herstellungsverfahren dafür
ATE244249T1 (de) Kristallinisches aminsalz von cefdinir
ATE329014T1 (de) Mikrobielle transglutaminasen, ihre herstellung und ihre verwendung
HUP0000527A2 (hu) Eljárás tolterodin előállítására és az intermedier
DE69824875D1 (de) Katalysator für membranelektrodenanordnung und herstellungsverfahren
DE69012180T2 (de) Halogenbeständiges Wasserstoffbehandlungsverfahren und Katalysator.
HUT42084A (en) Process for producing new 4-benzyl-1-/2h/-phtalazinone derivatives
ATE348075T1 (de) Rückgewinnung des ammoniaksynthesekatalysators
ATE330970T1 (de) Neue anti-hiv immunogene (toxoide), herstellungsverfahren und verwendungen zur behandlung und vorbeugung von aids
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
NO975663D0 (no) Semikarbazoner med CNS aktivitet og farmasöytiske preparater inneholdende de samme
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
ID29715A (id) Hidrogenasi berlanjut senyawa aromatik ternitrasi menggunakan katalis berkadar alumunium rendah
DE4480344T1 (de) Federstahl von hoher Festigkeit und hoher Zähigkeit, sowie Herstellungsverfahren dafür
TR200100370T2 (tr) Anti-konvülzan etkinliğe sahip yeni 4-amino-1-arilpiridin-2-on'lar ve bunların hazırlanması için işlemler.
DE69513186D1 (de) Photokatalysator, methode zur dessen herstellung, und erzeugung von wasserstoff unter verwendung des photokatalysators
DE69526181T2 (de) Katalysator und Wasserstoffbehandlungsverfahren
FR2754181B1 (fr) Nouvelles utilisations de compositions a base d'alpha-lactalbumine
NZ333229A (tr)
FR2367734A1 (fr) Nouvelles polyamines tertiaires utiles comme catalyseurs des polyurethanes
DE69833557D1 (de) Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern
DE69012883D1 (de) Methode für die Behandlung von Abgas.
DE69816832D1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
HUP0104214A2 (hu) Javított eljárás alfa-klór-nitrilek előállítására
MX220674B (en) Process for hydrolysis of adiponitrile and prodn. of nylon 6,6 utilizing low catalyst levels